SCHEMBL2196276

SCHEMBL2196276

O=C(c1cc(O)ccc1F)c1ccc(Nc2ccc(F)cc2)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 8/20 0.49
MAPK12 P53778 8/20 0.49
MAPK11 Q15759 8/20 0.49
MAPK14 Q16539 8/20 0.49
GRM4 Q14833 1/20 0.42
SOS1 Q07889 1/20 0.41
XDH P47989 1/20 0.41
SLC22A12 Q96S37 1/20 0.41
P2RX1 P51575 1/20 0.40
CLK1 P49759 1/20 0.39
DYRK1A Q13627 1/20 0.39
DYRK1B Q9Y463 1/20 0.39
EGFR P00533 1/20 0.38
ERBB3 P21860 1/20 0.38
PYGL P06737 1/20 0.38
HPGD P15428 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GRIK1 P39086 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2199363 0.88 MAPK14 (0.56) MAPK13MAPK12MAPK11MAPK14SOS1
SCHEMBL2198443 0.88 MAPK14 (0.56) MAPK13MAPK12MAPK11MAPK14GRM4
SCHEMBL2198903 0.85 MAPK14 (0.71) MAPK13MAPK12MAPK11MAPK14PYGL
SCHEMBL2196274 0.81 MAPK13 (0.59) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2198500 0.79 MAPK14 (0.45) MAPK13MAPK12MAPK11MAPK14GRM4
SCHEMBL2202011 0.78 MAPK13 (0.45) MAPK13MAPK12MAPK11MAPK14GRM4
SCHEMBL2201141 0.77 MAPK13 (0.67) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2199862 0.76 TP53 (0.49) CLK1DYRK1ADYRK1BHPGDNPC1
SCHEMBL2854379 0.73 MAPK14 (0.58) MAPK13MAPK12MAPK11MAPK14NPC1
SCHEMBL2866594 0.73 MAPK13 (0.58) MAPK13MAPK12MAPK11MAPK14NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977387-B2 Aminobenzophenone compounds LEO PHARMA A/S (DK) 2011-07-12 US disclosed
CN-1826310-B Novel aminobenzophenone compounds LEO PHARMA AS 2010-07-21 CN disclosed
CN-1826310-A Novel aminobenzophenone compounds LEO PHARMA AS (DK) 2006-08-30 CN disclosed
US-20060166990-A1 Novel aminobenzophenone compounds LEO PHARMA A/S (DK) 2006-07-27 US disclosed
EP-1658263-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS Leo Pharma A/S (DK) 2006-05-24 EP disclosed
WO-2005009940-A1 NOVEL AMINOBENZOPHENONE COMPOUNDS LEO PHARMA A/S (DK) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060166990-A1 Novel aminobenzophenone compounds NFKBIA, UACA, ALDH7A1 MAPK13 1063/4885MAPK12 955/4885MAPK11 612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.